Aberdeen Group’s Cognyte Software CGNT Stock Holding History

Aberdeen Group’s Portfolio CGNT Stock Details CGNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-290,034	Closed	-$5.96M	–	1050
2021 Q3	$5.96M	Sell	290,034 -750,738	-72%	-$19.2M	0.01%	625
2021 Q2	$29.2M	Buy	1,040,772 +273,278	+36%	+$6.76M	0.06%	276
2021 Q1	$21.5M	Buy	+767,494	New	+$22.8M	0.05%	326

Other funds holding CGNT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Kabouter Management Chicago, Illinois $15.6M AUM 16.79% 1-Year Est. Return

ACM

American Capital Management New York $1.86B AUM 20.23% 1-Year Est. Return

RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return

Aberdeen Group's CGNT Position: Q4 2021 in Review

Aberdeen Group sold out of Cognyte Software (CGNT) in Q4 2021, closing a stake of 290,034 shares — an estimated $5.96M sold.

Aberdeen Group first reported a position in CGNT in Q1 2021 and held it in 3 quarters. The position peaked at $29.2M in Q2 2021. 164 funds tracked by Wall St. Rank hold CGNT as of Q4 2021.

Aberdeen Group reported no remaining Cognyte Software position as of Q4 2021 after selling out during the quarter.
Aberdeen Group sold 290,034 Cognyte Software shares in Q4 2021, an estimated $5.96M.
Aberdeen Group first reported a position in Cognyte Software in Q1 2021 and held it in 3 quarters.
Aberdeen Group's Cognyte Software position peaked at $29.2M in Q2 2021.
164 funds tracked by Wall St. Rank held Cognyte Software as of Q4 2021.

Based on Aberdeen Group's 13F filing for Q4 2021, filed 8 Feb 2022.